UPDATE: Claros Mortgage Trust Q3 Sales $76.42M Beat $65.59M Estimate

Claros Mortgage Trust (NYSE:CMTG) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.34 by 2.94 percent. This is a 2.94 percent decrease over earnings of $0.34 per share from

Claros Mortgage Trust (NYSE:CMTG) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.34 by 2.94 percent. This is a 2.94 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $76.42 million which beat the analyst consensus estimate of $65.59 million by 16.51 percent. This is a 18.74 percent increase over sales of $64.36 million the same period last year.

Total
0
Shares
Related Posts
Read More

Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that a new composition of matter patent has been allowed by the United States Patent and Trademark Office (USPTO). The patent was allowed following expedited review by the USPTO. 

ATHE